EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Postoperative radiotherapy after resection of esophageal small-cell neuroendocrine carcinoma: a multicenter retrospective cohort study

Wenpeng Jiao iD, Xu Wang, Fuhui Zhang, Danqing Li, Yao Liu, Jia Han, Jiantao Li, Hidetaka Uramoto, Sohsuke Yamada

Diseases of the Esophagus · 02.09.2026 · 39 (5)

DOI: 10.1093/dote/doag121 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diseases of the Esophagus, online erschienen am 29.10.2026. Verfasst von Wenpeng Jiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chest Radiotherapy Department 1, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Carcinoma, Small Cell, Esophageal Neoplasms, Esophagectomy. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of postoperative radiotherapy after resection of esophageal small-cell neuroendocrine carcinoma remains uncertain. We evaluated associations with survival and recurrence while addressing treatment timing, confounding, and treatment-effect heterogeneity. We retrospectively analyzed 127 patients from three centers. Diagnosis required small-cell morphology plus synaptophysin and CD56 positivity. Radiotherapy and adjuvant chemotherapy were modeled as time-dependent exposures. Sensitivity analyses included a 90-day landmark design and propensity-score overlap weighting. Treatment-effect heterogeneity was assessed using interaction terms with Holm correction, and recurrence was analyzed using competing-risk methods. A cohort of 43 patients was analyzed descriptively. Radiotherapy was not associated with overall survival in the adjusted time-dependent model (hazard ratio, 1.472; 95% confidence interval, 0.820–2.641; P = 0.195), the 90-day landmark model (hazard ratio, 1.734; 95% confidence interval, 0.934–3.221; P = 0.081), or the overlap-weighted model (hazard ratio, 1.001; 95% confidence interval, 0.550–1.820; P = 0.999). Adjuvant chemotherapy showed a protective direction without statistical significance after adjustment (hazard ratio, 0.569; 95% confidence interval, 0.230–1.407; P = 0.222). No clinicopathological or biomarker-defined factor significantly modified the radiotherapy–survival association after Holm correction. First-failure patterns differed by radiotherapy status, with lower locoregional and higher distant-failure incidence among treated patients; these associations were descriptive because of residual treatment-selection bias. External-cohort estimates were nonsignificant and nonconfirmatory. This study did not demonstrate an overall survival benefit from postoperative radiotherapy and does not provide evidence supporting its routine use or patient selection based on nodal or biomarker status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineCarcinoma, Small CellEsophageal NeoplasmsEsophagectomyAgedFemaleHumansMaleMiddle AgedChemotherapy, AdjuvantNeoplasm Recurrence, LocalPostoperative CareRadiotherapy, AdjuvantRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

chemotherapyesophageal cancerradiation therapy

Autor:innen und Institutionen

  • Chest Radiotherapy Department 1, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Japan.
  • Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • The Second Department of Radiotherapy and Chemotherapy, Tangshan People's Hospital, Tangshan, China.
  • Department of Radiation Oncology, Xingtai People's Hospital, Xingtai, China.
  • Department of Diagnostic Pathology, Kanazawa Medical University Hospital, Uchinada, Japan.

ORCID-Profile: Wenpeng Jiao

Zitieren

APA

Jiao, W., Wang, X., Zhang, F., Li, D., Liu, Y., Han, J., Li, J., Uramoto, H., & Yamada, S. (2026). Postoperative radiotherapy after resection of esophageal small-cell neuroendocrine carcinoma: a multicenter retrospective cohort study. Diseases of the Esophagus, 39(5). https://doi.org/10.1093/dote/doag121

Vancouver

Jiao W, Wang X, Zhang F, Li D, Liu Y, Han J, et al. Postoperative radiotherapy after resection of esophageal small-cell neuroendocrine carcinoma: a multicenter retrospective cohort study. Diseases of the Esophagus. 2026;39(5). doi:10.1093/dote/doag121

BibTeX
@article{Jiao2026,
  author = {Jiao, Wenpeng and Wang, Xu and Zhang, Fuhui and Li, Danqing and Liu, Yao and Han, Jia and Li, Jiantao and Uramoto, Hidetaka and Yamada, Sohsuke},
  title = {Postoperative radiotherapy after resection of esophageal small-cell neuroendocrine carcinoma: a multicenter retrospective cohort study},
  journal = {Diseases of the Esophagus},
  year = {2026},
  volume = {39},
  number = {5},
  doi = {10.1093/dote/doag121}
}
Kostenlos starten →